Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 3 | 2941 | 145 | 0.8865 | 0.7710 | 0.0493 | 0.0544 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 2 | 2697 | 158 | 0.8050 | 0.7710 | 0.0586 | 0.0544 |
WM-115 | Vemurafenib | I-BET151 | 0.000 | 1.000 | uM | 72 | hr | 2 | 2815 | 155 | 0.7624 | 0.7766 | 0.0551 | 0.0532 |
WM-115 | Vemurafenib | I-BET151 | 0.000 | 1.000 | uM | 72 | hr | 1 | 3143 | 166 | 0.8533 | 0.7766 | 0.0528 | 0.0532 |
WM-115 | Vemurafenib | I-BET151 | 0.000 | 1.000 | uM | 72 | hr | 3 | 2628 | 136 | 0.7142 | 0.7766 | 0.0518 | 0.0532 |
WM-115 | Vemurafenib | I-BET | 0.316 | 0.000 | uM | 72 | hr | 1 | 2875 | 195 | 0.7688 | 0.7817 | 0.0678 | 0.0634 |
WM-115 | Vemurafenib | I-BET | 0.316 | 0.000 | uM | 72 | hr | 3 | 2983 | 183 | 0.8032 | 0.7817 | 0.0613 | 0.0634 |
WM-115 | Vemurafenib | I-BET | 0.316 | 0.000 | uM | 72 | hr | 2 | 2870 | 175 | 0.7731 | 0.7817 | 0.0610 | 0.0634 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.316 | 0.000 | uM | 72 | hr | 3 | 2794 | 188 | 0.7996 | 0.7819 | 0.0673 | 0.0740 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.316 | 0.000 | uM | 72 | hr | 1 | 2680 | 212 | 0.7572 | 0.7819 | 0.0791 | 0.0740 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.316 | 0.000 | uM | 72 | hr | 2 | 2781 | 210 | 0.7888 | 0.7819 | 0.0755 | 0.0740 |
MMAC-SF | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 1093 | 67 | 0.8186 | 0.7894 | 0.0613 | 0.0654 |
MMAC-SF | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 1098 | 69 | 0.8210 | 0.7894 | 0.0628 | 0.0654 |
MMAC-SF | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 984 | 71 | 0.7285 | 0.7894 | 0.0722 | 0.0654 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 3 | 591 | 30 | 0.5509 | 0.7915 | 0.0508 | 0.0491 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 1095 | 43 | 1.0331 | 0.7915 | 0.0393 | 0.0491 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 2 | 854 | 49 | 0.7905 | 0.7915 | 0.0574 | 0.0491 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 1047 | 45 | 0.7995 | 0.7976 | 0.0430 | 0.0486 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 981 | 39 | 0.7516 | 0.7976 | 0.0398 | 0.0486 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 1126 | 71 | 0.8418 | 0.7976 | 0.0631 | 0.0486 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 2 | 894 | 41 | 0.8637 | 0.8032 | 0.0459 | 0.0480 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 1 | 736 | 41 | 0.7037 | 0.8032 | 0.0557 | 0.0480 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 3 | 869 | 37 | 0.8424 | 0.8032 | 0.0426 | 0.0480 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 3 | 950 | 43 | 0.8907 | 0.8036 | 0.0453 | 0.0497 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 2 | 913 | 53 | 0.8445 | 0.8036 | 0.0581 | 0.0497 |